The Capital Graph

One identity, every relationship, every date — traced to the filing.

One record, walked through the questions a buyer actually asks — every answer a screen, every value cited. (Illustrative record.)

Question one

Is this the same person?

Five filings, five spellings, no shared identifier. The graph decides whether they are one person — and shows the evidence it used — before anything gets connected. This is where the "wrong person" never gets in.

KS GraphResolution

As filed

Form 4

PROSPECT, J. M.

Reporting owner · Acme Therapeutics, Inc. · CIK 0002128417 · signed 14 Feb 2026

990

J. Prospect

Part VII, trustee · Acme Family Foundation · address 12 Elm Street

ADV

Prospect, Jordan

Schedule A, direct owner · Northwind Capital Advisors · CRD 7318842

Form D

Jordan M. Prospect

Item 3, executive officer · Northwind Robotics, Inc. · signatory

Property

PROSPECT JORDAN M

Owner of record · 12 Elm Street · sale recorded 3 Sep 2024

Resolved

Jordan M. Prospect

one identity · 5 sources · id ks:p/8f3a…

SEC CIK carried across Form 4 and Form Dmatch
12 Elm Street on 990 and county property recordmatch
Northwind on ADV and Form D, same officer rolematch
Signature block, Form D vs Form 4match

Not merged: Jordan Prospect, CFO, Redwood Holdings (Form 4, CIK 0001955120) — different CIK, different state, no shared address. Kept as a separate identity.

Every merge keeps its reasons, so a compliance reviewer can see why two filings became one person — and why a third one didn't.

Question two

What did we know, and when?

Drag the date. The record is reproducible as of any past day — dated, never restated — so a backtest or a diligence memo can be rebuilt exactly as it stood.

as of 14 Mar 2026

Prospectone identity · 5 sources

2 Jun 202514 Feb 202614 Mar 2026

RelationshipCounterpartySourceAs ofAgree

officer ofAcme Therapeutics, Inc.Form 4 · 14 Feb2026-02-123 / 3

holds384,000 sh · 10b5-1 planForm 4 Table I2026-02-122 / 2

co-foundedNorthwind Robotics, Inc.Form D · company site2025-06-023 / 3

raisedSeries B · $48MRelease 09:14 · Form D2026-01-212 / 2

principal atNorthwind Capital AdvisorsForm ADV Sch. A2026-02-102 / 2

trustee ofAcme Family FoundationIRS 990 Part VIIFY20242 / 2

holds title to12 Elm Street · $2.9MCounty sale record2024-09-031 / 1

Next liquidity event · 14 Mar 202696,000 sh vest — from the Form 4 that says so

Question three

Who else is connected?

No filing lists the companies that share a director with Acme Therapeutics. The fact only exists as structure across thousands of separate records. There is nothing to retrieve — but there is something to traverse.

KS GraphReverse screen

›Public companies that share a director with Acme Therapeutics3 results · 0.4s · as of 10 Mar 2026

Company	Shared director	Role at Acme	Role there	Source	Agree
BioNova, Inc.NASDAQ · BNVA	Jordan M. Prospect	Director, officer	Independent director since 2023	DEF 14ABNVA · 2025	2 / 2
Helix LabsNYSE · HLX	Michael Chen	Independent director	Audit chair	DEF 14AForm 4	3 / 3
Castlegate DiagnosticsNASDAQ · CGDX	Michael Chen	Independent director	Director, comp committee	DEF 14ACGDX · 2025	2 / 2

Also true, and provable: none of Acme's 14 directors has sat on a board that was delisted or filed for bankruptcy — 0 of 41 prior boards.bounded universe · every prior board checked

The same query runs from the other end: prospects in your donor file who sit on a board with one of your trustees; family offices that co-invested with a fund; advisers whose principals hold a stake in a company you're watching.

Question four

Can you prove it?

Every value clicks back to the record that asserts it — the filing, the table, the row, the sentence, the accession number. Nothing is modeled; nothing is inferred.

KS GraphProvenance

384,000 sh held · Jordan M. Prospect, officer of Acme Therapeutics

Form 4 Table I · row 2 — Common Stock, acquired & held
"…following the reported transaction, the reporting person beneficially owns 384,000 shares of Common Stock."
Accession 0002128417-26-000091 · filed 14 Feb 2026 · EDGAR
3 independent records agree — Form 4, 10b5-1 plan, prior Form 4

Illustrative record; accession shown is fictional. Real facts carry the live accession and a link to the exact page.

Why a graph, not just a prompt

What your AI can't answer alone

A strong model with web search is great for one large-cap; it breaks where names are ambiguous and patterns span filings — which is where our markets live.

LLM + web search Retrieval only

Same LLM + the Capital Graph Retrieval + structure

Namesakes

Retrieval matched a director to a namesake CEO at an unrelated public company — and invented a career

Resolved by identifier, not by name — the wrong person never enters the answer

Patterns across filings

14 directors × prior companies × outcomes is 30–40 retrieval hops, each a chance to drift

One traversal — the path is the query

Questions with no document

"Which companies share a director with this one" has nothing to retrieve

Structure answers it — the edge already exists

Proving a negative

Can only say "I didn't find any"

A bounded universe says "zero delistings, zero bankruptcies" — and proves it

Point your agent at the graph: the MCP server hands the same model resolved, cited, point-in-time answers instead of leaving it to retrieve and guess. See the real case →

For your team

One graph, built for how your team works.

Advancement & Foundations Wealth Managers & Advisors VC, Family Offices & PE Hedge Funds, Quants & Data Teams Credit & Fixed Income Bankers & Corporate Development

See your market in the graph.

Start a trial, or see what it does for your team.

Request a trial → Explore solutions →

Coverage differs by type: SEC, 990 and ADV run deep; property, loans and private-company people are newer and growing, and are labeled as such.